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Background: Currently, data are not available concerning a safe insufflation pressure that provides a proper view of
the surgical field without adverse metabolic and hemodynamic changes in humans undergoing the robot-assisted
thyroidectomy bilateral axillo-breast approach (BABA) using the da Vinci robotic surgical system. The purpose of this
study was to determine the optimal carbon dioxide (CO2) insufflation pressure in patients with various benign and
malignant thyroid diseases when using the da Vinci robotic surgical system.
Methods: A total of 32 patients underwent thyroid surgery at 6 (n = 15), 9 (n = 15), and 12 (n = 2) mmHg. The
partial pressure of carbon dioxide (PaCO2), pH, cardiac output, heart rate, and mean arterial pressure were measured
at baseline, 30 min and 1, 1.5, and 2 hours after CO2 insufflation, and 30 min after desufflation.
Results: CO2 insufflation of 12 mmHg caused severe facial subcutaneous emphysema, hypercarbia, and acidosis
during robot-assisted thyroidectomy with BABA. The study was stopped before completion for the patients’ safety
in accordance with the study protocol. Applying 6- or 9- mmHg of CO2 insufflation pressure caused increases in
PaCO2 and decreases in arterial pH. However, vital signs were stable and pH and PaCO2 were within the physiologic
range during the surgery in the 6- and 9-mmHg groups.
Conclusions: We propose that a CO2 insufflation pressure under 10 mmHg in robot-assisted thyroidectomy with
BABA is the optimal insufflation pressure for patient safety.
Keywords: Benign and malignant thyroid diseases, Bilateral axillo-breast approach, Da Vinci, Carbon dioxide
insufflation, Pressure, Robot-assisted thyroid surgeryBackground
Since endoscopic neck surgery was introduced into clin-
ical practice in 1995 by Gagner [1], robot-assisted thyroi-
dectomy via the bilateral axillo-breast approach (BABA)
using the da Vinci robotic surgical system has been suc-
cessfully used for various benign and malignant thyroid
diseases with a low rate of adverse effects and excellent
cosmetic outcomes [2,3]. BABA is performed by using
two circumareolar ports and two axillary ports, which is* Correspondence: monday1031@yahoo.co.kr
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reproduction in any medium, provided the oruseful for identifying anatomy and dissection during sur-
gery [3,4]. The endo-wrist function of the instrument in
the da Vinci robotic surgical system makes it possible to
employ complex techniques, even in difficult areas with
limited access.
During laparoscopic surgery, carbon dioxide (CO2) gas
is usually insufflated into the body cavity, and an elec-
tronic variable-flow insufflator controls the insufflation
pressure [5]. A higher CO2 insufflation pressure allows a
better view of the surgical field. However, because the
insufflation pressure can affect the severity of hypercar-
bia, balancing the insufflation pressure between a better
view of the surgical field and preventing hypercarbia is
very important. In laparoscopic surgery, the insufflation. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to prevent significant hypercarbia [5,6].
The use of CO2 insufflation in the neck potentially
causes adverse metabolic and hemodynamic changes as
well as tachycardia and massive subcutaneous emphy-
sema [7]. According to Bellantone et al., hypercarbia,
moderate acidosis, and a slight increase in mean arterial
pressure occurred in pigs undergoing endoscopic neck
surgery at 15 mmHg [8]. They proposed that CO2 neck
insufflation is safe at 10 mmHg. Therefore, during endo-
scopic neck surgery, the authors empirically used 6
mmHg of CO2 as the maximal CO2 insufflation pressure
in BABA endoscopic thyroidectomy [3,4]. However, con-
crete data supporting the rationale of using 6 mmHg of
CO2 insufflation pressure in endoscopic thyroidectomy
with BABA have not been published. In addition, no
data are currently available concerning a safe insufflation
pressure that can provide a proper view of the surgical
field without adverse metabolic and hemodynamic
changes in humans undergoing robot-assisted thyroi-
dectomy with BABA by using the da Vinci robotic surgi-
cal system (RaBABA).
Therefore, the purpose of the present study was to de-
termine the optimal CO2 insufflation pressure in
patients undergoing RaBABA.
Methods
After obtaining approval from the institutional review
board and written informed consent, 32 patients with
American Society of Anesthesiologists (ASA) physical
status I–II undergoing elective RaBABA were randomly
assigned to the three groups described below. The ages
of the patients ranged from 18 to 60 years.
Patients were randomly assigned to one of the three
groups. The groups were named on the basis of the CO2
gas pressure used to insufflate the peritoneal cavity.
Patients with previous neck or breast surgery, severe
cardiopulmonary disease, morbid obesity, and neck or
vertebral abnormality were excluded from this study.
The patients were premedicated with midazolam
(2 mg) and glycopyrrolate (0.2 mg) intramuscularly 30
min before anesthesia. Standard monitoring included
electrocardiogram, noninvasive arterial blood pressure,
pulse oximetry, end-tidal CO2, bispectral index, and ex-
piratory gas concentration. Anesthesia was induced with
intravenous propofol and was maintained with 50% ni-
trous oxide in oxygen and an end-tidal concentration of
2 to 3 vol% of sevoflurane. Intravenous rocuronium
bromide was used to facilitate tracheal intubation. The
radial artery was cannulated with a 20-gauge catheter to
monitor arterial blood pressure. The VigileoTM System
(FloTrac, Edwards Lifesciences, Irvine, CA, USA) was
connected to the arterial line to monitor the cardiac index
(CI) and cardiac output (CO). Mechanical ventilation wasmaintained with oxygen with air (FiO2 0.5) at a constant
tidal volume (8 mL/kg) and frequency (12 breaths/min)
during the study. Lactated Ringer’s solution was used for
volume replacement during surgery.
If any one of the termination criteria was met during
the surgery, insufflation pressure was reduced to below 5
mmHg. If the study was terminated in two consecutive
cases within the same group, the study group was
excluded and a new randomization code was generated
between the remaining groups. The termination criteria
of the study were as follows: (1) persistent acidosis
(pH ≤7.15) or hypercarbia (partial pressure of carbon di-
oxide (PaCO2) ≥50 mmHg) for 30 min; (2) the mean
blood pressure decreased to below 50 mmHg; (3) the CI
decreased to below 2 L/min; (4) the heart rate increased
to over 110 beat/min; and (5) the occurrence of serious
adverse events, such as subcutaneous emphysemas, as
determined by the attending anesthesiologists.
All operations were performed by a single surgical
team. According to previous reports [3,4], the patient
was prepared in the supine position with a pillow placed
under the shoulders to maintain neck extension with
both arms naturally abducted on both sides. After the
vital signs were stabilized, base line blood gases and
hemodynamic parameters were recorded. The flaps were
raised using a vascular tunneler, and bilateral axillary
and two circumareolar 8 mm to 12 mm ports were
inserted. The flap extended from the superior border of
the thyroid cartilage to the 4-cm inferior area under the
clavicle and laterally from just beyond the lateral margin
of sternocleidomastoid. At this point, CO2 insufflation
was performed, the pressure of CO2 insufflation was
determined by the designated group, and the time 0 of
insufflation was recorded. The working space was main-
tained by continuous CO2 insufflation pressure. Total
thyroidectomy via the BABA approach using the da
Vinci robot system was performed using the general
methods [3,4].
Heart rate, mean arterial pressure (MAP), pH, PaCO2
(arterial), CI and CO were measured at baseline, 0 min,
30 min, 1 hour, 1.5 hours, and 2 hours after CO2 insuf-
flation and desufflation, and at 30 min after desufflation.
Statistical analysis was conducted using SigmaStat 3.5
for Windows (Systat Software, Inc., Chicago, IL, USA).
Variables between groups were compared using the two-
sample t-test or Mann–Whitney rank sum test. Variables
at each time point within a group were compared using
repeated measures analysis of variance. A P value <0.05
was considered statistically significant.
Results and discussion
Enrollment, group assignment, and analysis of patients
In total, 32 patients were included in this study. These
patients were randomly allocated to three groups: the 6-
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the 12-mmHg group (n = 2). Severe facial subcutaneous
emphysema was observed at 15 and 30 minutes after the
initiation of CO2 insufflation in the two patients in
whom the surgery was conducted using a CO2 insuffla-
tion pressure of 12 mmHg. Furthermore, rapid progres-
sion of hypercarbia and acidosis was observed. The
study was stopped midway in accordance with the ter-
mination criteria. In addition, the 12-mmHg group was
dropped because two consecutive cases developed severe
facial subcutaneous emphysemas, hypercarbia, and acid-
osis. The remaining patients in the 12-mmHg group
were randomly allocated to the other two groups and
successfully participated in this study. Statistically sig-
nificant differences were not observed in any of the vari-
ables, including neck circumstance before and after CO2
insufflation, between the two groups (Table 1).
Analysis of hemodynamic parameters
Differences in MAP, heart rate (HR), CO, and CI were
not observed between the groups at any of the time
points. After desufflation, the MAP was increased com-
pared to the baseline value in the 9-mmHg group
(P <0.05) (Figure 1). The HR of the 9-mmHg group was
increased compared to the baseline value at 30 min after
insufflation, but returned to the baseline level after 1
hour (Figure 2). The CO and CI did not show statisti-
cally significant differences compared to the baseline
values at any of the time points (Figure 3).
Analysis of metabolic parameters
Patients undergoing surgery did not develop acidosis or
hypercarbia in the 6- or 9-mmHg groups (Figures 4, 5).
Changes in pH and PaCO2 were within the physiologic
range at each time point. In addition, no differences in
pH and PaCO2 were observed between the groups at
any of the time points. In the 6-mmHg group, decreased
pH and increased PaCO2 compared to the baseline value
was observed at 30 min and at 1, 1.5, and 2 hours after
insufflation. The pH and PaCO2 levels returned to the
baseline value at 30 min after desufflation. In the 9-mmHgTable 1 Demographic characteristics and baseline data
6 mmHg 9 mmHg
Age (years) 46.8 ± 8.4 36.0 ± 6.7
Weight (kg) 58.4 ± 6.8 58.5 ± 6.8
Height 158.9 ± 5.1 160.0 ± 4.0
Volume of CO2 insufflation (L) 1,390.6 ± 417.3 1,662.3 ± 553.3
Duration of CO2 insufflation (min) 240.3 ± 48.8 220.6 ± 49.9
Neck circumstance before CO2
insufflation
16.0 ± 2.8 15.8 ± 1.3
Neck circumstanceafter CO2 insufflation 16.8 ± 3.3 16.7 ± 1.3
Data are expressed as the mean± SD. Statistically significant differences in the
variables were not observed between the two groups.group, decreased pH and increased PaCO2 compared to
baseline was observed at 30 min and 1, 1.5, and 2 hours
after insufflation. PaCO2 levels returned to the baseline
value at 30 min after desufflation. However, the pH was
decreased until 30 min after desufflation.
Our results showed that a CO2 insufflation pressure of
12 mmHg caused severe facial subcutaneous emphy-
sema, hypercarbia, and acidosis during RaBABA. Al-
though applying 6- or 9-mmHg of CO2 insufflation
pressure increased PaCO2 and decreased arterial pH, the
vital signs were stable and pH and PaCO2 were within
the physiologic range during surgery.
Subcutaneous emphysema is a frequent complication
during endoscopic surgery [5,9]. Subcutaneous emphy-
sema aggravates hypercarbia and acidosis because of
an increase in the total gas exchange area [10]. Got-
tlieb et al. [7] reported that massive subcutaneous em-
physema, hypercarbia, supraventricular tachycardia, and
acidosis occurred in a patient undergoing endoscopic
trans-cervical parathyroidectomy at a CO2 insufflation
pressure of 20 mmHg. According to Bellantone et al.,
hypercarbia, moderate acidosis, and a slight increase in
mean arterial pressure occurred in pigs undergoing
endoscopic neck surgery at 15 mmHg [7]. In addition,
a CO2 insufflation of 15 mmHg caused CO2 accumula-
tion and acute hypercarbia, which can lead to intracra-
nial angiectasis, increased brain blood volume, and
subsequent intracranial hypertension [11,12]. Therefore,
the severe facial subcutaneous emphysema experienced
by the two patients in the 12-mmHg group was an
anticipated event before the collection of study data.
However, because several previous studies [7,8] sug-
gested that using an insufflation pressure of 10 to 15
mmHg was safe in endoscopic neck surgery in an ani-
mal model, we hoped that 12 mmHg would provide a
better view of the surgical field without adverse meta-
bolic and hemodynamic changes.
From the surgeon’s point of view, 9 mmHg pressure of
CO2 insufflation may give us several advantages over 6
mmHg pressure of insufflation when performing
RaBABA. First, 9 mmHg insufflation provides wider op-
erative space than 6 mmHg insufflation. Unlike the case
with non-articulating linearly moving instruments used
in conventional endoscopic thyroidectomy, various kinds
of articulating instruments which enable almost 360
degrees of freedom of movement are applied through
the robotic arms during robotic thyroidectomy, and to
use the articulating instruments effectively a wider op-
erative space is needed than is in conventional endo-
scopic thyroidectomy. In other words, higher flap and
wider operative space are necessary to fully take advan-
tage of robotic arm movements during RaBABA. This
wider space may be achieved by the maximal safe CO2
insufflation pressure which turned out to be 9 mmHg in
Figure 1 Changes in mean arterial pressure (MAP). A slight increase in MAP at 30 min after desufflation compared to the baseline (P<0.05)
was observed in the 9-mmHg group. Significant differences were not observed between the groups. Data are expressed as the mean± SD. *
P<0.05 versus baseline value.
Kim et al. World Journal of Surgical Oncology 2012, 10:202 Page 4 of 7
http://www.wjso.com/content/10/1/202this study. Second, a higher raised flap in higher CO2
insufflation pressure helps to keep the surgeon's view
clear for a longer time and lessens the need to cleanse
the lens of the endoscopic camera during RaBABA. The
surgeons performing RaBABA are hindered by the visual
disturbance that results from the contamination of the
endoscopic camera lens by subcutaneous and subplatys-
mal fat tissues, especially in obese patients. A more
highly elevated flap in 9 mmHg CO2 insufflation pres-
sure than in 6 mmHg helps to keep the camera view
clear for a longer operative time in these obese patients
undergoing RaBABA. Third, in turn, higher insufflation
pressure can be somewhat helpful in diminishing the
total operation time of RaBABA, especially in obese
patients. However, in our study, there was no statisticallyFigure 2 Changes in heart rate (HR). Although a slight increasing trend
increase in HR at insufflation and 30 min after insufflation compared to the
differences were not observed between the groups. Data are expressed assignificant difference in total operation time between the
6 mmHg and 9 mmHg groups (240.3 min in the 6 mmHg
group versus 220.6 min in the 9 mmHg group), which
might be a result of the limited numbers of enrolled
patients in the two groups and also the lack of morbidly
obese patients in either group.
Because CO2 has a high solubility, the absorption dose
of CO2 is proportional to CO2 pressure and the duration
of insufflation [13]. CO2 gas is easily diffused in loose
areolar and rough tissue [14], such as in the neck. In
previous studies performed in a porcine model, PaCO2
increased and pH decreased slightly without acidosis or
adverse hemodynamic changes in the 10-mmHg group
[8,15]. In our study, arterial CO2 and pH were changed
after CO2 insufflation in the 6- and 9-mmHg groups.was observed in HR over time, this change was tolerable. A slight
baseline (P<0.05) was observed in the 9-mmHg group. Significant
the mean± SD. * P< 0.05 versus baseline value.
Figure 3 Changes in cardiac output (CO). Changes in CO were tolerable even at 9 mmHg of insufflation. Significant differences were not
observed between the groups. Data are expressed as the mean± SD.
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ever, the changes in pH and PaCO2 were within the
physiologic range in the 6- and 9-mmHg groups during
the insufflation period. Hypercarbia due to CO2 insuffla-
tion can cause epinephrine and norepinephrine release,
resulting in hypertension and tachycardia [16]. However,
the blood pressure (BP) response to hypercarbia varies
and cannot always be used as a diagnostic sign [16,17].
In addition, although tachycardia commonly occurs with
hypercarbia during CO2 insufflation [5,6,16], previous
studies revealed that changes in HR were inconsistent
[17,18]. In our study, the BP did not change during theFigure 4 Changes in pH. Decreasing pH was observed at 30 min and 1, 1
baseline in the 6-mmHg group (P<0.05). After desufflation, pH levels return
was observed at 30 min and at 1, 1.5, and 2 hours after CO2 insufflation an
baseline in the 9-mmHg group. Significant differences were not observed b
versus baseline value.insufflation period but the HR was slightly increased im-
mediately after insufflation. However, the change in HR
was tolerable and self-limited.
This study had several limitations. Our results showed
that the CO was not changed in the 6- or 9-mmHg
groups compared to the baseline value during the study
period. The continuous thermodilution technique using
a catheter placed in the pulmonary artery is widely used
to assess CO in critically ill patients [19,20]. Although
this method is believed to be quite accurate under most
clinical conditions [21,22], the process of acquiring cen-
tral venous access and a balloon floating through the.5, and 2 hours after insufflation and desufflation compared to the
ed to the baseline at 30 min in the 6-mmHg group. Decreasing pH
d desufflation, and at 30 min after desufflation compared with the
etween the groups. Data are expressed as the mean± SD. * P<0.05
Figure 5 Changes in PaCO2. Increasing PaCO2 was observed at 30 min and 1, 1.5, and 2 hours after insufflation and at desufflation compared
with the baseline in the 6- and 9-mmHg groups (P<0.05). At 30 min after desufflation, PaCO2 levels returned to the baseline in the 6- and 9-
mmHg groups Significant differences were not observed between the groups. Data are expressed as the mean± SD. * P<0.05 versus baseline
value.
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times fatal [23,24]. The Vigileo/FloTrac is a valuable tool
for the management of patients with diseases such as
cardiovascular dysfunction and critical illness or in those
undergoing major surgery [25,26] or who are exposed to
situations of changing arterial pulse contour [27-29].
Thus, we used the Vigileo/FloTrac to measure CO. A
study that used the thermodilution technique with a
Swan−Ganz catheter in a porcine model reported that
CO increased in the 10-, 15-, and 20-mmHg groups, but
these changes were not statistically significant; these
results are quite similar to our findings herein.
Conclusions
In conclusion, we propose that a CO2 insufflation pres-
sure below 10 mmHg in robot-assisted thyroidectomy
with BABA is an optimal insufflation pressure.
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